Form 8-K - Current report:
SEC Accession No. 0001104659-25-052407
Filing Date
2025-05-23
Accepted
2025-05-23 16:01:19
Documents
12
Period of Report
2025-05-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2516012d1_8k.htm   iXBRL 8-K 40571
  Complete submission text file 0001104659-25-052407.txt   206686

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA rigl-20250522.xsd EX-101.SCH 3005
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE rigl-20250522_lab.xml EX-101.LAB 34239
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rigl-20250522_pre.xml EX-101.PRE 22352
14 EXTRACTED XBRL INSTANCE DOCUMENT tm2516012d1_8k_htm.xml XML 3707
Mailing Address 611 GATEWAY BOULEVARD, SUITE 900 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BOULEVARD, SUITE 900 SOUTH SAN FRANCISCO CA 94080 650-624-1100
RIGEL PHARMACEUTICALS INC (Filer) CIK: 0001034842 (see all company filings)

EIN.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-29889 | Film No.: 25981985
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)